• AusCann’s 50:50 joint venture in Chile, DayaCann, has secured its second cultivation licence
• Licence allows the JV to commence cultivation activities immediately at its facility in Chile
• This is the only licence granted in Chile to cultivate medical cannabis
• Chile represents a significant market, with a large patient population, supportive regulatory framework for medical cannabis companies and wider access to Latin America
• Follows the successful harvest of the JV’s first crop in Chile earlier this year of over 400kg
• Provides further support for the JV to become fully integrated across the full spectrum of the Latin America medicinal cannabis supply chain
AusCann Group Holdings Ltd (ASX:AC8 or ‘the Company’) is pleased to announce that its joint venture (JV) in Chile, DayaCann, has secured a further licence for the cultivation of medical cannabis crops at its Chilean facility.
For further information please download PDF attached:
Download this document
